US endocrine review supports low-dose effects theory

A US expert panel on endocrine disrupting compounds has concluded that low-dose effects "have been clearly demonstrated" for some oestrogenic compounds. However, it says that more research is needed on the disputed issue of low-dose effects from exposure to the plastics intermediate bisphenol A.

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here


Call: 020 8267 8120

Take a 30-day trial

  • Join ENDS Report now and pay nothing for your first 30-days.



Prices on request

  • Full access to for 12 months
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits

Need to activate your subscription?
Already a subscriber
If you haven't already, activate your subscription here>>
Company Domain Access
If your company or university has a corporate subscription simply register your email address here to gain access